
Pricing drugs, selling hype and how we got here in the first place
May 15, 2018 - 15:46
Radio and PodcastLive Radio & Podcasts
Fierce editors discuss the discussion around Gilead Sciences' huge cash reserve and the many things the company might buy. Plus, a look back at AbbVie's blockbuster buyout of Pharmacyclics and a thoughtful consideration...
The burning hole in Gilead's $25B pocket and AbbVie's future in hematology is an episode from FierceBiotech Radio. Fierce editors discuss the discussion around Gilead Sciences' huge cash reserve and the many things the company might buy. Pl...
This episode belongs to FierceBiotech Radio.
Use the player on this page to stream the episode online.
Published Dec 10, 2015, 19:52 long, audio available.
Fierce editors discuss the discussion around Gilead Sciences' huge cash reserve and the many things the company might buy. Plus, a look back at AbbVie's blockbuster buyout of Pharmacyclics and a thoughtful consideration of how a certain biotech entrepreneur is bringing attention to an FDA loophole.
You can listen to The burning hole in Gilead's $25B pocket and AbbVie's future in hematology online on Radio and Podcast. Open the player on this page to stream the available audio.
The burning hole in Gilead's $25B pocket and AbbVie's future in hematology is an episode from FierceBiotech Radio.
This episode is 19:52 long.
This episode was published on Dec 10, 2015.
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Yes. This page shows related episodes from FierceBiotech Radio when more episodes are available from the podcast feed.
You can listen to The burning hole in Gilead's $25B pocket and AbbVie's future in hematology on this page when the episode audio is available from the podcast feed.
The burning hole in Gilead's $25B pocket and AbbVie's future in hematology is from FierceBiotech Radio.
Published Dec 10, 2015 and 19:52 long